Experimental Antidepressant Appears Quick-Acting, Safe
Currently in phase 2 trials, drug would not be available for several yearsContinue Reading
Currently in phase 2 trials, drug would not be available for several yearsContinue Reading
New strategies needed to combat tobacco addiction in people with certain genetic makeups, study saysContinue Reading
One year of the drug was as effective as two in study of women with certain type of diseaseContinue Reading
Costly drug comes with serious side effects, researchers sayContinue Reading
Study suggests mental fog, fatigue tied to chemotherapy may be partly due to stressContinue Reading
Using the so-called ‘performance-enhancing’ hormone can harm health, experts warnContinue Reading
Study found that patients were three times likelier to benefit from the addition of cognitive behavioral therapyContinue Reading
Study supports early intervention, before surgery, for patients under 35Continue Reading
Diuretics can hurt lean patients, researchers sayContinue Reading
Study found benzodiazepines, used for anxiety and sleep, also boosted chances of dying from pneumoniaContinue Reading
Research found extended-release Budeprion at 300 mg dose was not equivalent to brand-name version of antidepressantContinue Reading
Extended course of antibiotics doesn’t reduce repeat infections, study findsContinue Reading
Survival lengthened in studies of two experimental treatmentsContinue Reading
Taking drug longer further reduced breast cancer recurrence, deaths, researcher saysContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.